Vandria is a startup based in the Netherlands, most recent round Series-c-plus, 1 tracked investor.
Vandria is a company headquartered in the Netherlands. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Vandria is a biopharmaceutical company developing first-in-class small molecule mitophagy inducers to treat age-related and chronic diseases, including CNS, muscle, lung, and liver disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.